Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chi-Huang
- Development stage
- Preclinical
- Administration
- Topical
01
Overview
Chi-Huang is a traditional Chinese medicine (TCM) topical formulation investigated primarily for its anti-inflammatory and anti-pruritic effects, especially in dermatological contexts such as allergic contact dermatitis and canine atopic dermatitis. Experimental data in murine models indicate that Chi-Huang cream reduces skin lesions, scratching, and skin thickness, with efficacy comparable to hydrocortisone butyrate and fewer adverse effects. Its use as a solution has been researched for allergic pruritus in both animals and humans, and it is considered a promising TCM therapy for chronic pruritus, showing immunomodulatory and anti-inflammatory properties[1][2][3].
- Brand names
- Chi-Huang
- Other names
- Chi-Huang creamChi-Huang solutionCH-H
Beyond the preview
Go deeper on Chi-Huang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chi-Huang.